| Model Number |
M00513730 |
| Medical Device Problem Codes |
Positioning Failure (1158); Activation, Positioning or Separation Problem (2906)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/19/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported to boston scientific corporation that an ultraflex esophageal ng distal release covered stent was to be implanted in the esophagus during an esophageal stent placement procedure performed on (b)(6) 2023.During the procedure, the stent could not be deployed.Another esophageal stent was used to complete the procedure.There were no reported patient complications as a result of this event.The patient's condition following the procedure was reported to be stable.No further information has been obtained despite good faith efforts.Note: this event has been deemed an mdr reportable event based on the investigation finding of stent partially deployed.Please see block h10 for the full investigation details.
|
| |
|
Additional Manufacturer Narrative
|
|
Block h6: imdrf device code a15 captures the reportable investigation finding of stent partially deployed.Block h10: the ultraflex esophageal ng distal release covered stent and delivery system were received for analysis.A visual inspection was performed and revealed the stent was partially deployed on the delivery system and that the shaft was bent.The deployment suture was inspected, and no damages or knots were noted.Functional examination was performed, and the stent was released gradually from the delivery system by holding the handle hub in the palm of one hand and grasping and retracting the finger ring with the other hand.No other damages were noted with the stent or delivery system.Although the stent was returned partially deployed on the delivery system; product analysis could not confirm the reported event of stent unable to deploy as the stent was released from the delivery system without resistance during device analysis.The investigation concluded that the damages observed were most likely due to procedural factors such as characteristics of the lesion, handling of the device, and the technique, limited the performance of the device and contributed to stent being unable to deploy.Therefore, review and analysis of all available information indicated the most probable cause adverse event related to procedure.A product labeling review identified that the device was used per the directions for use (dfu)/product label.
|
| |
|
Search Alerts/Recalls
|